The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

Novo Nordisk appoints Maziar Mike Doustdar as the new CEO to tackle falling sales and shares amid stiff competition in the ...

Wall Street chugged mostly higher in premarket trading as Chinese and U.S. officials begin a second day of trade talks.

U.S. stock futures edged higher Tuesday, with investors awaiting the release of more corporate earnings as well as key ...

Novo Nordisk has lowered its sales and profit forecasts for the second time this year due to competitive pressures in the ...

Novo Nordisk (NVO) stock falls as the company names a new CEO and cuts outlook citing pressure on obesity drug sales. Eli ...

Novo Nordisk cut its full-year guidance as U.S. sales continue to be hurt by copycat versions of its blockbuster Wegovy ...

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background.

Novo Nordisk A/S lowered its financial forecast in a surprise update that cited lagging sales of its weight-loss drug Wegovy, as the company fights to regain its leading position in the obesity market ...

PayPal topped Wall Street estimates for the quarter and raised full-year guidance, as CEO Alex Chriss pushes profitability over volume.